Biotest
BIO.F
#4861
Rank
$1.45 B
Marketcap
$44.27
Share price
0.00%
Change (1 day)
-0.70%
Change (1 year)

P/E ratio for Biotest (BIO.F)

P/E ratio as of October 2024 (TTM): -158

According to Biotest 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -158.3. At the end of 2022 the company had a P/E ratio of -51.6.

P/E ratio history for Biotest from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-51.697.02%
2021-26.2-25.48%
2020-35.1-72.49%
2019-128-2375.15%
20185.61-102.73%
2017-2051385.86%
2016-13.857.93%
2015-8.76-114.33%
201461.199.51%
201330.665.68%
201218.577.59%
201110.4-33.03%
201015.5-13.68%
200918.0

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.